Drugmakers Eisai and Biogen claim success in Alzheimer’s drug study
Published
Pharma groups to seek regulatory approval after trial shows treatment slowed down disease
Full ArticlePublished
Pharma groups to seek regulatory approval after trial shows treatment slowed down disease
Full Article